InvestSMART

Raptor Metals Ltd (ASX: RAP) - Announcements

- Current share price for RAP : $0.027

ASX company news and announcements for Raptor Metals Ltd (RAP) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Raptor Metals Ltd (RAP) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Raptor Metals Ltd (RAP), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Raptor Metals Ltd (RAP)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$11 Scheme Meeting - Chairman's Address & Presentation 7 Sep 2022 1:53PM $0.205 $0.027 fallen by 86.83%
$11 Becoming a substantial holder 5 Sep 2022 10:36AM $0.200 $0.027 fallen by 86.50%
$11 Appendix 4G 30 Aug 2022 9:08AM $0.190 $0.027 fallen by 85.79%
$11 Corporate Governance Statement 30 Aug 2022 8:56AM $0.190 $0.027 fallen by 85.79%
$11 Appendix 4E and Annual Report 30 Aug 2022 8:45AM $0.190 $0.027 fallen by 85.79%
$11 Dispatch of Second Supplementary Scheme Booklet 29 Aug 2022 3:36PM $0.188 $0.027 fallen by 85.60%
$11 Second Supplementary Scheme Booklet 25 Aug 2022 2:01PM $0.188 $0.027 fallen by 85.60%
$11 Correction to ASX announcement 19 Aug 2022 2:33PM $0.188 $0.027 fallen by 85.60%
$11 Adjournment of Scheme Meeting to a date to be determined 19 Aug 2022 2:12PM $0.188 $0.027 fallen by 85.60%
$11 Best and Final Confirmation and Bridging Loan 16 Aug 2022 5:27PM $0.180 $0.027 fallen by 85%
$11 Dispatch of Supplementary Scheme Booklet 8 Aug 2022 6:34PM $0.195 $0.027 fallen by 86.15%
$11 Pfizer raises scheme consideration to A$0.208 per share 5 Aug 2022 5:52PM $0.190 $0.027 fallen by 85.79%
$11 Correction to ASX announcement 3 Aug 2022 4:58PM $0.180 $0.027 fallen by 85%
$11 Entry into amended and restated Scheme Implementation Deed 3 Aug 2022 10:43AM $0.123 $0.027 fallen by 77.96%
$11 Investor Conference Call Notification 2 Aug 2022 5:37PM $0.120 $0.027 fallen by 77.50%
$11 Quarterly Activities Report and Appendix 4C 27 Jul 2022 9:22AM $0.115 $0.027 fallen by 76.52%
$11 Quarterly Results and Investor Conference Call Notification 25 Jul 2022 9:16AM $0.120 $0.027 fallen by 77.50%
$11 Study shows efficacy of ResAppDx use with masks 22 Jul 2022 9:20AM $0.125 $0.027 fallen by 78.40%
$11 Dispatch of Scheme Booklet 20 Jul 2022 4:35PM $0.135 $0.027 fallen by 80%
$11 Clarification - Scheme Booklet registered with ASIC 20 Jul 2022 4:27PM $0.135 $0.027 fallen by 80%
$11 Scheme Update - ACCC condition precedent satisfied 18 Jul 2022 12:22PM $0.135 $0.027 fallen by 80%
$11 Scheme Booklet registered with ASIC 18 Jul 2022 11:52AM $0.135 $0.027 fallen by 80%
$11 Results of First Court Hearing 15 Jul 2022 5:14PM $0.135 $0.027 fallen by 80%
$11 Medgate Licence Agreement Clarification Announcement 11 Jul 2022 9:10AM $0.130 $0.027 fallen by 79.23%
$11 Medgate extends licence agreement and plans to expand use 7 Jul 2022 9:06AM $0.130 $0.027 fallen by 79.23%

51 - 75 of 568 results

Page 3 of 23

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.